GIT1 and metastatic malignant neoplasm in the lymph nodes: Finally, we examined the relationship between GIT1 expression and the clinicopathologic characteristics of NSCLC (Table 1) and found that a high level of GIT1 was positively correlated with lymph node metastasis (P = 0.023) and early recurrence (P = 0.036).